top of page
Executive Spotlights

Guillaume Pfefer, Ph.D., MBA, will become Sail's CEO

Cambridge, MA, October 19, 2023 (PRNewswire) -- Flagship Pioneering merges Laronde and Senda Biosciences to create Sail Biomedicines. Dr. Guillaume Pfefer, CEO-Partner at Flagship Pioneering, will lead Sail Biomedicines as CEO and board member, focusing on the innovation of fully programmable medicines to advance patient care.

Read full article here.

Recent Posts

See All

Rahway, NJ & Cambridge, MA, November 21, 2023 (Business Wire) -- Merck (NYSE: MRK), also known as MSD outside of the United States and Canada, and Caraway Therapeutics, Inc. declare a definitive agr

Life Science Headlines
bottom of page